Stay updated on news regarding the Kanzius Foundation and the Kanzius Noninvasive Radiowave Cancer Treatment by receiving our quarterly newsletter, the wave!
The Kanzius Noninvasive Radiowave Cancer Treatment is an alternative cancer treatment to current therapies and surgeries, which are known for their dreadful, and often long-lasting, side effects. The Kanzius treatment has displayed the ability to eradicate cancer cells without damaging the healthy surrounding cells, noninvasively and with no side effects using only three basic elements: radiowaves, nanoparticles, and antibodies. When combined to treat cancer, these three simple components create promise for an effective, dignified and groundbreaking alternative to treat cancer patients.
The promise of finding a better way to treat cancer fuels the focus and drive of the Kanzius RF Laboratory team. Up unto this point, the research of the Kanzius Noninvasive Radiowave Cancer Treatment has proven to be extremely successful and has made monumental strides towards reaching human trials. The research of the Kanzius Noninvasive Radiowave Cancer Treatment is currently being conducted by lead researchers Dr. Steven Curley of the University of Texas M.D. Anderson Cancer Center and Dr. David Geller of The University of Pittsburgh Medical Center.
Research is currently underway to treat the following nine cancers with the Kanzius Noninvasive Radiowave Cancer Treatment:
As your interest in the Kanzius Noninvasive Radiowave Cancer Treatment increases, gather more knowledge about the continued research from published journal articles. The manuscripts are published from the Kanzius research team. All of the published journal articles are available.